DCW Q1 FY27 Results (NSE: DCW)
Signal: Steady quarter
The read
The operating trajectory deteriorated despite 14.0% revenue growth: gross margin compressed 1,021bps, EBITDA fell 28.3% to ₹4,141 lakh and EBIT fell 53.7% to ₹1,515 lakh; the 203.3% PAT increase to ₹3,454.63 lakh is primarily a non-operating deferred-tax gain and is not evidence of an earnings recovery.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹541.91 Cr | 14.0% | -11.0% |
| EBIT | ₹15.15 Cr | -53.7% | |
| Net profit | ₹34.55 Cr | 203.3% | |
| EPS | ₹1.17 | 200.0% | |
| EBIT margin | 7.6% |
P&L walk
Revenue increased to ₹54,190.97 lakh, +14.0% YoY, but gross margin compressed to 25.4% from 35.6% as raw-material and inventory-related costs rose faster than sales; EBITDA declined 28.3% to ₹4,141 lakh, while PAT of ₹3,454.63 lakh was driven by the ₹3,427.92 lakh deferred-tax gain rather than operating performance.
Segments
Basic Chemicals dragged the result with revenue of ₹36,091.97 lakh, +5.4% YoY, and a ₹2,768.48 lakh loss versus a ₹265.43 lakh loss YoY, while Speciality Chemicals grew revenue 37.7% to ₹17,698.74 lakh and generated ₹4,053.89 lakh of segment profit.
Key positives
- Speciality Chemicals revenue reached ₹17,698.74 lakh, +37.7% YoY, materially ahead of consolidated revenue growth of 14.0%, and delivered ₹4,053.89 lakh of segment profit.
- Finance costs rose only 2.2% YoY to ₹1,539.91 lakh despite 14.0% revenue growth, limiting balance-sheet drag in the quarter.
- Segment assets increased 3.4% YoY to ₹2,30,504.85 lakh alongside a 4.9% increase in depreciation to ₹2,625.96 lakh, a broadly clean capex-to-depreciation signal.
Key concerns
- Gross margin compressed to 25.4% from 35.6% YoY as raw materials consumed increased to 61.9% of revenue from 54.7%; the filing does not disclose the cause, indicating cost absorption rather than demonstrated pricing power.
- Basic Chemicals moved to a ₹2,768.48 lakh segment loss from a ₹265.43 lakh loss YoY while revenue growth was only 5.4%, making it the principal operating drag.
- Employee benefits expense increased 50.4% YoY to ₹6,873.13 lakh, far faster than revenue growth of 14.0%, while EBITDA declined 28.3% to ₹4,141 lakh.
- Reported PAT of ₹3,454.63 lakh includes a ₹3,427.92 lakh deferred-tax gain; underlying PBT was only ₹35.69 lakh versus ₹1,766.53 lakh YoY.
Earnings quality: includes non-operating other income
Research and educational content only. Not investment advice.